The Centers for Medicare & Medicaid Services (CMS) has unveiled its proposed rule for the 2027 Medicare Physician Fee Schedule (MPFS), signaling a transformative shift in how the federal government compensates healthcare providers for digital health services. Among the most consequential updates are sweeping changes to the reimbursement framework for Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM). These proposals represent a rigorous effort by the agency to address mounting concerns regarding fraudulent billing practices, the clinical efficacy of outsourced monitoring services, and the evolving costs of the technology involved. By prioritizing the direct clinical relationship between physicians and patients, CMS aims to pivot away from a model that has increasingly relied on third-party vendors and toward a more integrated, practice-led approach to care.
Strategic Shift Toward Direct Clinical Supervision
At the core of the proposed 2027 rule is a significant policy change that would effectively bar reimbursement for remote monitoring services delivered by third-party companies. Under the new proposal, CMS intends to limit payment for RPM and RTM to services performed exclusively by clinical staff who are directly employed by the billing physician or the billing practice. This marks a departure from current "general supervision" standards that have allowed external vendors to handle the bulk of data collection and patient interaction on behalf of a practice.
CMS’s rationale for this change is rooted in the belief that remote monitoring should be a tool for enhancing existing patient-provider relationships rather than a standalone, outsourced service line. By requiring direct employment, the agency seeks to ensure that the data collected—such as blood pressure, heart rate, or glucose levels—is being monitored by professionals who are intimately familiar with the patient’s medical history and overall care plan. This move is expected to have a profound impact on the "RPM-as-a-service" industry, which has grown rapidly over the last several years by offering turnkey solutions to medical practices.
Furthermore, the agency is proposing a mandatory, separate billable visit to initiate any remote patient monitoring episode. This "kick-off" visit would serve as a formal evaluation and management (E/M) encounter where the physician determines the medical necessity of the monitoring, educates the patient on the device’s use, and establishes clear clinical goals for the monitoring period.
Addressing the Findings of the OIG 2024 Report
The catalyst for these stringent new regulations can be traced back to a series of investigations by the Department of Health and Human Services (HHS) Office of Inspector General (OIG). In a 2024 report, the OIG flagged significant levels of fraud, waste, and abuse within the Medicare remote monitoring space. The report highlighted a growing trend of "unsolicited outreach," where third-party companies would contact Medicare beneficiaries directly, often through telemarketing schemes, to enroll them in monitoring programs regardless of whether their primary care physician had recommended the service.
The OIG’s investigation uncovered several alarming patterns:
- Billing for Unperformed Services: Many companies were found to be billing Medicare monthly for setup, patient education, and ongoing monitoring that was never actually provided.
- Equipment Irregularities: In numerous instances, the monitoring equipment was never delivered to the patient, or the devices provided were not FDA-approved for the specific medical purpose being billed.
- Lack of Staffing Capacity: The OIG determined that some vendors were enrolling thousands of patients simultaneously without having the necessary clinical staff to actually review the incoming data, rendering the monitoring medically useless.
- Incomplete Service Delivery: Approximately 43% of Medicare enrollees receiving RPM did not receive all three required components of the service: education and setup (CPT 99453), the device supply (CPT 99454), and the requisite 20 minutes of treatment management (CPT 99457).
By tightening the requirements for who can perform the monitoring and requiring a formal initiation visit, CMS is attempting to close the loopholes that have allowed these "billing mills" to proliferate at the expense of the Medicare Trust Fund.
Revaluation of Technology and Code Consolidation
Beyond fraud prevention, the 2027 proposed rule reflects an updated economic assessment of the digital health landscape. CMS noted that the market for remote monitoring devices has matured significantly since the original billing codes were established. The agency pointed out that the cost of cellular-connected devices—such as blood pressure cuffs, scales, and pulse oximeters—has dropped considerably. As a result, the current reimbursement rates for "device supply" may no longer reflect the actual overhead costs incurred by practices.
In a signal of even deeper structural changes to come, CMS is soliciting public comments on a proposal to collapse the current suite of RPM billing codes into four streamlined codes. Currently, the system relies on a complex array of codes (99453, 99454, 99457, and 99458) to distinguish between setup, device supply, and various increments of monitoring time. The proposed consolidation aims to simplify the billing process while potentially adjusting the overall valuation of the services to align with current market prices for technology and labor.
Tightened Eligibility for Remote Therapeutic Monitoring (RTM)
The proposed rule also brings Remote Therapeutic Monitoring (RTM) under tighter scrutiny. While RPM focuses on physiologic data automatically collected by devices, RTM is designed to track non-physiologic data, such as medication adherence, respiratory system status, and musculoskeletal pain levels, often through patient self-reporting.
Under the new proposal, RTM eligibility would be restricted to patients who have a pre-existing, established relationship with the billing practice. This is intended to prevent RTM from being used as a "cold-start" service by external vendors who have no prior clinical knowledge of the patient. CMS emphasized that for therapeutic monitoring to be effective, it must be integrated into a comprehensive treatment plan managed by a provider who is already overseeing the patient’s specific condition.
Chronology of Remote Monitoring in Medicare
The evolution of remote monitoring reimbursement has moved rapidly over the last decade, transitioning from a niche service to a mainstream component of chronic disease management:
- 2018: CMS first introduced CPT code 99091, allowing for the reimbursement of time spent collecting and interpreting stored physiologic data.
- 2019: The agency introduced the more specific RPM codes (99453, 99454, 99457), which allowed for separate billing of device setup and monthly monitoring.
- 2020-2022: The COVID-19 pandemic accelerated the adoption of these services. CMS implemented temporary waivers that eased supervision requirements, fueling a surge in the use of third-party RPM vendors.
- 2024: The OIG released its comprehensive audit, revealing that Medicare lacked the basic data needed to oversee RPM billing effectively, such as the identity of the ordering physician.
- 2026 (Proposed): CMS issues the 2027 MPFS proposed rule, seeking to retract many of the flexibilities that led to the program’s rapid but troubled expansion.
Broader Implications and Industry Reaction
The proposed changes have sent ripples through the digital health industry. While professional medical associations, such as the American Medical Association (AMA), have generally supported the move toward stronger clinical integration, the vendor community is bracing for significant disruption. Many RPM companies whose business models are built on providing "clinical labor" to practices may find their current contracts non-compliant under the proposed 2027 standards.
For healthcare providers, the "direct employment" requirement presents a dual challenge. While it ensures better control over patient data and quality of care, it also increases the administrative and payroll burden on small to mid-sized practices that may not have the resources to hire dedicated staff for monitoring. Analysts suggest this could lead to a further consolidation of medical practices into larger health systems that can afford the necessary internal infrastructure.
From a value-based care perspective, these changes are seen as a necessary step in the maturation of telehealth. By tying reimbursement more closely to outcomes and established clinical relationships, CMS is signaling that remote monitoring is no longer an "extra" service, but a core component of modern medical practice that must meet the same rigorous standards as in-person care.
Next Steps and Implementation Timeline
The release of the proposed rule initiates a 60-day public comment period, during which stakeholders—including physicians, technology vendors, and patient advocacy groups—can provide feedback to CMS. This feedback is often instrumental in shaping the final version of the rule.
The final 2027 Medicare Physician Fee Schedule is expected to be published in late 2026. If the proposals are finalized as written, the new regulations, including the third-party billing ban and the initiation visit requirement, will take effect on January 1, 2027. Providers and digital health companies now face a critical window to evaluate their current operations and prepare for a regulatory environment that prioritizes clinical accountability over outsourced convenience.
